Brief Reports
Copyright ©The Author(s) 2005.
World J Gastroenterol. Aug 28, 2005; 11(32): 5032-5036
Published online Aug 28, 2005. doi: 10.3748/wjg.v11.i32.5032
Table 1 Expression of CD44v6, VEGF, MMP-2, and MMP-9 in epithelial ovarian carcinoma, Krukenberg tumor, and gastric carcinoma
CD44v6
VEGF
MMP-2
MMP-9
nn%n%n%n%
Normal ovarian tissue20210.015.0
Epithelial ovarian cancer451635.61431.1817.8613.3
Serous adenocarcinoma15640.0746.7426.7320.0
Mucous adenocarcinoma16425.0318.8212.5212.5
Other types14642.9428.6214.317.1
Krukenberg tumor382771.12771.13181.63181.6
Moderate differentiation14964.31071.41285.61071.4
Poor differentiation241875.01770.81979.22187.5
Gastric carcinoma383078.92773.72565.82360.5
High and moderate differentiation161275.0956.3731.8637.5
Poor differentiation221881.81672.71881.81777.3
Table 2 Relation between expressions of CD44v6, VEGF, MMP-2, and MMP-9 in Krukenberg tumor
CD44v6
MMP-2
MMP-9
rPrPrP
VEGF0.3420.0230.4980.0000.4980.000
CD44v60.4190.0050.2130.212
MMP-20.4880.001
Table 3 Relation between expressions of CD44v6, VEGF, MMP-2, and MMP-9 in primary epithelial ovarian carcinoma
CD44v6
MMP-2
MMP-9
rPrPrP
VEGF0.6050.0040.6080.0030.7110
CD44v60.6840.0010.8040
MMP-20.4570.037
Table 4 Relation between expressions of CD44v6, VEGF, MMP-2, and MMP-9 in primary gastric carcinoma
CD44v6
MMP-2
MMP-9
rPrPrP
VEGF0.3660.0460.250.3780.3850.035
CD44v60.460.0110.2000.475
MMP-20.4390.015